Özgür Sahin (Ozgur Sahin)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 37

Top Venues

Cancer research

bioRxiv : the preprint server for biology

Cell cycle (Georgetown, Tex.)

Cell death & disease

University of South Carolina

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of South Carolina

United States

Associate Professor :: Department of Drug Discovery and Biomedical Sciences

Publications

Mustafa Emre Gedik, Ozge Saatci, Nathaniel Oberholtzer, Meral Uner, Ozge Akbulut-Caliskan, Metin Cetin, Mertkaya Aras, Kubra Ibis, Burcu Çalışkan, Erden Banoglu, Stefan Wiemann, Aysegül Uner, Sercan Aksoy, Shikhar Mehrotra, Özgür Sahin
Targeting TACC3 Induces Immunogenic Cell Death and Enhances T-DM1 Response in HER2-Positive Breast Cancer. Cancer research 84 (9) (2024)
Ozge Saatci, Rashedul Alam, Kim-Tuyen Huynh-Dam, Aynur Isik, Meral Uner, Nevin Belder, Pelin Gulizar Ersan, Unal Metin Tokat, Burge Ulukan, Metin Cetin, Kubra Calisir, Mustafa Emre Gedik, Hilal Bal, Ozlem Sener Sahin, Yasser Riazalhosseini, Denis Thieffry, Daniel Gautheret, Besim Ogretmen, Sercan Aksoy, Aysegul Uner, Aytekin Akyol, Özgür Sahin
Targeting LINC00152 activates cAMP/Ca 2+ /ferroptosis axis and overcomes tamoxifen resistance in ER+ breast cancer. Cell death & disease 15 (6) (2024)
Amanda C Daulagala, Metin Cetin, Joyce Nair-Menon, Douglas W Jimenez, Mary Catherine Bridges, Amy D Bradshaw, Özgür Sahin, Antonis Kourtidis
The epithelial adherens junction component PLEKHA7 regulates ECM remodeling and cell behavior through miRNA-mediated regulation of MMP1 and LOX. bioRxiv : the preprint server for biology (2024)
Mustafa Emre Gedik, Ozge Saatci, Nathaniel Oberholtzer, Meral Uner, Ozge Akbulut-Caliskan, Metin Cetin, Mertkaya Aras, Kubra Ibis, Burcu Çalışkan, Erden Banoglu, Stefan Wiemann, Aysegül Uner, Sercan Aksoy, Shikhar Mehrotra, Özgür Sahin
Targeting TACC3 Induces Immunogenic Cell Death and Enhances T-DM1 Response in HER2-Positive Breast Cancer. Cancer research 84 (9) (2024)
Ozge Saatci, Özgür Sahin
TACC3: a multi-functional protein promoting cancer cell survival and aggressiveness. Cell cycle (Georgetown, Tex.) 22 (23-24) (2024)
Mustafa Emre Gedik, Ozge Saatci, Nathaniel Oberholtzer, Meral Uner, Ozge Akbulut-Caliskan, Metin Cetin, Mertkaya Aras, Kubra Ibis, Burcu Çalışkan, Erden Banoglu, Stefan Wiemann, Aysegül Uner, Sercan Aksoy, Shikhar Mehrotra, Özgür Sahin
Targeting TACC3 Induces Immunogenic Cell Death and Enhances T-DM1 Response in HER2-Positive Breast Cancer. Cancer research 84 (9) (2024)
Ozge Saatci, Rashedul Alam, Kim-Tuyen Huynh-Dam, Aynur Isik, Meral Uner, Nevin Belder, Pelin Gulizar Ersan, Unal Metin Tokat, Burge Ulukan, Metin Cetin, Kubra Calisir, Mustafa Emre Gedik, Hilal Bal, Ozlem Sener Sahin, Yasser Riazalhosseini, Denis Thieffry, Daniel Gautheret, Besim Ogretmen, Sercan Aksoy, Aysegul Uner, Aytekin Akyol, Özgür Sahin
Targeting LINC00152 activates cAMP/Ca 2+ /ferroptosis axis and overcomes tamoxifen resistance in ER+ breast cancer. Cell death & disease 15 (6) (2024)
Ozge Saatci, Rashedul Alam, Kim-Tuyen Huynh-Dam, Aynur Isik, Meral Uner, Nevin Belder, Pelin Gulizar Ersan, Unal Metin Tokat, Burge Ulukan, Metin Cetin, Kubra Calisir, Mustafa Emre Gedik, Hilal Bal, Ozlem Sener Sahin, Yasser Riazalhosseini, Denis Thieffry, Daniel Gautheret, Besim Ogretmen, Sercan Aksoy, Aysegul Uner, Aytekin Akyol, Özgür Sahin
Targeting LINC00152 activates cAMP/Ca 2+ /ferroptosis axis and overcomes tamoxifen resistance in ER+ breast cancer. Cell death & disease 15 (6) (2024)
Ozge Saatci, Özgür Sahin
TACC3: a multi-functional protein promoting cancer cell survival and aggressiveness. Cell cycle (Georgetown, Tex.) 22 (23-24) (2024)
Mustafa Emre Gedik, Ozge Saatci, Nathaniel Oberholtzer, Meral Uner, Ozge Akbulut-Caliskan, Metin Cetin, Mertkaya Aras, Kubra Ibis, Burcu Çalışkan, Erden Banoglu, Stefan Wiemann, Aysegül Uner, Sercan Aksoy, Shikhar Mehrotra, Özgür Sahin
Targeting TACC3 induces immunogenic cell death and enhances T-DM1 response in HER2-positive breast cancer. Cancer research (2024)
Amanda C Daulagala, Metin Cetin, Joyce Nair-Menon, Douglas W Jimenez, Mary Catherine Bridges, Amy D Bradshaw, Özgür Sahin, Antonis Kourtidis
The epithelial adherens junction component PLEKHA7 regulates ECM remodeling and cell behavior through miRNA-mediated regulation of MMP1 and LOX. bioRxiv : the preprint server for biology (2024)
Ozge Saatci, Özgür Sahin
TACC3: a multi-functional protein promoting cancer cell survival and aggressiveness. Cell cycle (Georgetown, Tex.) 22 (23-24) (2024)
Amanda C Daulagala, Metin Cetin, Joyce Nair-Menon, Douglas W Jimenez, Mary Catherine Bridges, Amy D Bradshaw, Özgür Sahin, Antonis Kourtidis
The epithelial adherens junction component PLEKHA7 regulates ECM remodeling and cell behavior through miRNA-mediated regulation of MMP1 and LOX. bioRxiv : the preprint server for biology (2024)
Ozge Saatci, Rashedul Alam, Kim-Tuyen Huynh-Dam, Aynur Isik, Meral Uner, Nevin Belder, Pelin Gulizar Ersan, Unal Metin Tokat, Burge Ulukan, Metin Cetin, Kubra Calisir, Mustafa Emre Gedik, Hilal Bal, Ozlem Sener Sahin, Yasser Riazalhosseini, Denis Thieffry, Daniel Gautheret, Besim Ogretmen, Sercan Aksoy, Aysegul Uner, Aytekin Akyol, Özgür Sahin
Targeting LINC00152 activates cAMP/Ca 2+ /ferroptosis axis and overcomes tamoxifen resistance in ER+ breast cancer. Cell death & disease 15 (6) (2024)
Ozge Saatci, Özgür Sahin
TACC3: a multi-functional protein promoting cancer cell survival and aggressiveness. Cell cycle (Georgetown, Tex.) (2024)
Mustafa Emre Gedik, Ozge Saatci, Nathaniel Oberholtzer, Meral Uner, Ozge Akbulut-Caliskan, Metin Cetin, Mertkaya Aras, Kubra Ibis, Burcu Çalışkan, Erden Banoglu, Stefan Wiemann, Aysegül Uner, Sercan Aksoy, Shikhar Mehrotra, Özgür Sahin
Targeting TACC3 Induces Immunogenic Cell Death and Enhances T-DM1 Response in HER2-Positive Breast Cancer. Cancer research 84 (9) (2024)
Amanda C Daulagala, Metin Cetin, Joyce Nair-Menon, Douglas W Jimenez, Mary Catherine Bridges, Amy D Bradshaw, Özgür Sahin, Antonis Kourtidis
The epithelial adherens junction component PLEKHA7 regulates ECM remodeling and cell behavior through miRNA-mediated regulation of MMP1 and LOX. bioRxiv : the preprint server for biology (2024)
Mustafa Emre Gedik, Ozge Saatci, Nathaniel Oberholtzer, Meral Uner, Ozge Akbulut-Caliskan, Metin Cetin, Mertkaya Aras, Kubra Ibis, Burcu Çalışkan, Erden Banoglu, Stefan Wiemann, Aysegül Uner, Sercan Aksoy, Shikhar Mehrotra, Özgür Sahin
Targeting TACC3 induces immunogenic cell death and enhances T-DM1 response in HER2-positive breast cancer. Cancer research (2024)
Mustafa Emre Gedik, Ozge Saatci, Nathaniel Oberholtzer, Meral Uner, Ozge Akbulut-Caliskan, Metin Cetin, Mertkaya Aras, Kubra Ibis, Burcu Çalışkan, Erden Banoglu, Stefan Wiemann, Aysegül Uner, Sercan Aksoy, Shikhar Mehrotra, Özgür Sahin
Targeting TACC3 induces immunogenic cell death and enhances T-DM1 response in HER2-positive breast cancer. Cancer research (2024)
Ozge Saatci, Rashedul Alam, Kim-Tuyen Huynh-Dam, Aynur Isik, Meral Uner, Nevin Belder, Pelin Gulizar Ersan, Unal Metin Tokat, Burge Ulukan, Metin Cetin, Kubra Calisir, Mustafa Emre Gedik, Hilal Bal, Ozlem Sener Sahin, Yasser Riazalhosseini, Denis Thieffry, Daniel Gautheret, Besim Ogretmen, Sercan Aksoy, Aysegul Uner, Aytekin Akyol, Özgür Sahin
Targeting LINC00152 activates cAMP/Ca 2+ /ferroptosis axis and overcomes tamoxifen resistance in ER+ breast cancer. Cell death & disease 15 (6) (2024)
Ozge Saatci, Özgür Sahin
TACC3: a multi-functional protein promoting cancer cell survival and aggressiveness. Cell cycle (Georgetown, Tex.) 22 (23-24) (2024)
Ozge Saatci, Özgür Sahin
TACC3: a multi-functional protein promoting cancer cell survival and aggressiveness. Cell cycle (Georgetown, Tex.) 22 (23-24) (2024)
Ozge Saatci, Metin Cetin, Meral Uner, Unal Metin Tokat, Ioulia Chatzistamou, Pelin Gulizar Ersan, Elodie Montaudon, Aytekin Akyol, Sercan Aksoy, Aysegul Uner, Elisabetta Marangoni, Mathew Sajish, Özgür Sahin
Toxic PARP trapping upon cAMP-induced DNA damage reinstates the efficacy of endocrine therapy and CDK4/6 inhibitors in treatment-refractory ER+ breast cancer. Nature communications 14 (1) (2023)
Ozge Saatci, Rashed Alam, Kim-Tuyen Huynh-Dam, Aynur Isik, Meral Uner, Nevin Belder, Pelin Gulizar Ersan, Metin Cetin, Unal Metin Tokat, Mustafa Emre Gedik, Hilal Bal, Ozlem Sener Sahin, Yasser Riazalhosseini, Denis Thieffry, Daniel Gautheret, Besim Ogretmen, Sercan Aksoy, Aysegul Uner, Aytekin Akyol, Özgür Sahin
Targeting LINC00152 activates cAMP/Ca 2+ /ferroptosis axis and overcomes tamoxifen resistance in ER+ breast cancer. bioRxiv : the preprint server for biology (2023)
Ozge Saatci, Rashed Alam, Kim-Tuyen Huynh-Dam, Aynur Isik, Meral Uner, Nevin Belder, Pelin Gulizar Ersan, Metin Cetin, Unal Metin Tokat, Mustafa Emre Gedik, Hilal Bal, Ozlem Sener Sahin, Yasser Riazalhosseini, Denis Thieffry, Daniel Gautheret, Besim Ogretmen, Sercan Aksoy, Aysegul Uner, Aytekin Akyol, Özgür Sahin
Targeting LINC00152 activates cAMP/Ca 2+ /ferroptosis axis and overcomes tamoxifen resistance in ER+ breast cancer. bioRxiv : the preprint server for biology (2023)
Ozge Saatci, Rashed Alam, Kim-Tuyen Huynh-Dam, Aynur Isik, Meral Uner, Nevin Belder, Pelin Gulizar Ersan, Metin Cetin, Unal Metin Tokat, Mustafa Emre Gedik, Hilal Bal, Ozlem Sener Sahin, Yasser Riazalhosseini, Denis Thieffry, Daniel Gautheret, Besim Ogretmen, Sercan Aksoy, Aysegul Uner, Aytekin Akyol, Özgür Sahin
Targeting LINC00152 activates cAMP/Ca 2+ /ferroptosis axis and overcomes tamoxifen resistance in ER+ breast cancer. bioRxiv : the preprint server for biology (2023)
Ozge Saatci, Ozge Akbulut-Caliskan, Metin Cetin, Vitali Sikirzhytski, Meral Uner, Deniz Lengerli, Elizabeth C O'Quinn, Martin J Romeo, Burcu Caliskan, Erden Banoglu, Sercan Aksoy, Aysegul Uner, Özgür Sahin
Targeting TACC3 represents a novel vulnerability in highly aggressive breast cancers with centrosome amplification. Cell death and differentiation (2023)
Mustafa Emre Gedik, Ozge Saatci, Nathaniel Oberholtzer, Meral Uner, Ozge Akbulut, Metin Cetin, Mertkaya Aras, Kubra Ibis, Burcu Caliskan, Erden Banoglu, Stefan Wiemann, Aysegul Uner, Sercan Aksoy, Shikhar Mehrotra, Özgür Sahin
Reviving immunogenic cell death upon targeting TACC3 enhances T-DM1 response in HER2-positive breast cancer. bioRxiv : the preprint server for biology (2023)
Ridho Assidicky, Unal Metin Tokat, Ibrahim Oguzhan Tarman, Ozge Saatci, Pelin Gulizar Ersan, Umar Raza, Hasan Ogul, Yasser Riazalhosseini, Tolga Can, Özgür Sahin
Targeting HIF1-alpha/miR-326/ITGA5 axis potentiates chemotherapy response in triple-negative breast cancer. Breast cancer research and treatment 193 (2) (2022)
Mithil Soni, Ozge Saatci, Gourab Gupta, Yogin Patel, Manikanda Raja Keerthi Raja, Jie Li, Xinfeng Liu, Peisheng Xu, Hongjun Wang, Daping Fan, Özgür Sahin, Hexin Chen
miR-489 Confines Uncontrolled Estrogen Signaling through a Negative Feedback Mechanism and Regulates Tamoxifen Resistance in Breast Cancer. International journal of molecular sciences 23 (15) (2022)
Marco Biondini, Alex Kiepas, Leeanna El-Houjeiri, Matthew G Annis, Brian E Hsu, Anne-Marie Fortier, Geneviève Morin, José A Martina, Isabelle Sirois, Adriana Aguilar-Mahecha, Tina Gruosso, Shawn McGuirk, April A N Rose, Unal Metin Tokat, Radia M Johnson, Özgür Sahin, Eric Bareke, Julie St-Pierre, Morag Park, Mark Basik, Jacek Majewski, Rosa Puertollano, Arnim Pause, Sidong Huang, Tibor Keler, Peter M Siegel
HSP90 inhibitors induce GPNMB cell-surface expression by modulating lysosomal positioning and sensitize breast cancer cells to glembatumumab vedotin. Oncogene 41 (12) (2022)
Helga Bergholtz, Jodi M Carter, Alessandra Cesano, Maggie Chon U Cheang, Sarah E Church, Prajan Divakar, Christopher A Fuhrman, Shom Goel, Jingjing Gong, Jennifer L Guerriero, Margaret L Hoang, E Shelley Hwang, Hellen Kuasne, Jinho Lee, Yan Liang, Elizabeth A Mittendorf, Jessica Perez, Aleix Prat, Lajos Pusztai, Jason W Reeves, Yasser Riazalhosseini, Jennifer K Richer, Özgür Sahin, Hiromi Sato, Ilana Schlam, Therese Sørlie, Daniel G Stover, Sandra M Swain, Alexander Swarbrick, E Aubrey Thompson, Sara M Tolaney, Sarah E Warren, null On Behalf Of The GeoMx Breast Cancer Consortium
Best Practices for Spatial Profiling for Breast Cancer Research with the GeoMx® Digital Spatial Profiler. Cancers 13 (17) (2021)
Esra Cicek, Ayca Circir, Merve Oyken, Ozge Akbulut-Caliskan, Didem Naz Dioken, Sezen Guntekin Ergun, Rengul Cetin-Atalay, Aysegul Sapmaz, Huib Ovaa, Özgür Sahin, Ayse Elif Erson-Bensan
EGF-SNX3-EGFR axis drives tumor progression and metastasis in triple-negative breast cancers. Oncogene (2021)
Ozge Saatci, Kim-Tuyen Huynh-Dam, Özgür Sahin
Endocrine resistance in breast cancer: from molecular mechanisms to therapeutic strategies. Journal of molecular medicine (Berlin, Germany) 99 (12) (2021)
Lin Wang, Luz M Londono, Jessica Cowell, Ozge Saatci, Mertkaya Aras, Pelin G Ersan, Sara Serra, Hong Pei, Renee Clift, Qiping Zhao, Kim B Phan, Lei Huang, Michael J LaBarre, Xiaoming Li, H Michael Shepard, Silvia Deaglio, Joel Linden, Christopher D Thanos, Özgür Sahin, Caglar Cekic
Targeting Adenosine with Adenosine Deaminase 2 to Inhibit Growth of Solid Tumors. Cancer research 81 (12) (2021)
Ozge Akbulut-Caliskan, Deniz Lengerli, Ozge Saatci, Elif Duman, Urartu Özgür Şafak Şeker, Aynur Isik, Aytekin Akyol, Burcu Caliskan, Erden Banoglu, Özgür Sahin
A Highly Potent TACC3 Inhibitor as a Novel Anticancer Drug Candidate. Molecular cancer therapeutics 19 (6) (2020)
Ozge Saatci, Aysegul Kaymak, Umar Raza, Pelin Gulizar Ersan, Ozge Akbulut-Caliskan, Carolyn E Banister, Vitali Sikirzhytski, Unal Metin Tokat, Zaliha Gamze Aykut, Suhail A Ansari, Hayriye Tatli Dogan, Mehmet Dogan, Pouria Jandaghi, Aynur Isik, Fatma Gündoğdu, Kemal Kosemehmetoglu, Omer Dizdar, Sercan Aksoy, Aytekin Akyol, Aysegül Uner, Phillip J Buckhaults, Yasser Riazalhosseini, Özgür Sahin
Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer. Nature communications 11 (1) (2020)

Özgür Sahin.css-eqlu8i{font-size:small;padding-left:4px;} (Ozgur Sahin)

Publication Activity (10 Years)

Top Topics

Top Venues

Özgür Sahin (Ozgur Sahin)